Understanding heart injury in patients with rapid atrial fibrillation
Official title: Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation
Run by University of Edinburgh · NCT06951100 · Data updated 2026-11-12
This study is trying to see if people with rapid atrial fibrillation and heart injury are more likely to have blocked arteries compared to those without heart injury, using blood tests and heart imaging.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Edinburgh Academic / other |
| Locations | 1 site (Edinburgh, East of England) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | December 2026 |
| Study ends | October 2029 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT06951100 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and over presenting with symptoms of rapid atrial fibrillation and a ventricular rate greater than 100 bpm.
✕Probably not a fit
Patients with a history of myocardial infarction, coronary revascularization, or significant renal failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the relationship between rapid atrial fibrillation (AF) and myocardial injury, focusing on the role of troponin levels and coronary imaging. It seeks to determine if patients with rapid AF and heart damage are more likely to have obstructive coronary artery disease compared to those without heart damage. Additionally, the study will assess whether these patients show signs of myocardial ischemia and infarction through various heart imaging techniques. Participants will undergo blood tests and advanced imaging, including electrocardiograms, echocardiograms, CT scans, and cardiac MRIs.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic strategies for patients with rapid atrial fibrillation and associated heart injuries.
How similar studies have gone: Other studies have explored similar relationships between atrial fibrillation and myocardial injury, suggesting potential for meaningful insights, though this specific approach may be novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years and over 2. Primary presentation with symptoms related to atrial fibrillation 3. Atrial fibrillation with a ventricular rate \>100 bpm on a 12-lead electrocardiogram 4. Able to provide informed consent Exclusion Criteria 1. Previous myocardial infarction 2. Previous coronary revascularisation procedure 3. Patients in renal failure (eGFR \<30ml/min/1.73m2) or major allergy to contrast media 4. Pregnancy or breast feeding 5. Deemed unsuitable for participation in the study by the attending clinician 6. Previous enrolment in the trial
Where it's running
-
Royal Infirmary of Edinburgh
Edinburgh, East of England, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.